Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistanceCamille Duluc, Corinne Bousquet, Siham Moatassim-Billah et al.|EMBO Molecular Medicine|2015Cited by 196
Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblastsSiham Moatassim-Billah, Corinne Bousquet, Camille Duluc et al.|Oncotarget|2016Cited by 39
Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With MacrophagesRémi Samain, Corinne Bousquet, Alexia Brunel et al.|Cellular and Molecular Gastroenterology and Hepatology|2021Cited by 32
Pharmacological targeting of the protein synthesis mTOR /4E‐ BP 1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistanceCamille Duluc, Corinne Bousquet, Siham Moatassim-Billah et al.|HAL (Le Centre pour la Communication Scientifique Directe)|2015Cited by 13
Targeting cancer-associated fibroblasts through inhibition of protein synthesis to abrogate resistance to chemotherapies in pancreatic cancerCamille Duluc, Corinne Bousquet, Siham Moatassim-Billah et al.|Pancreatology|2014Cited by 1